Saad Mark E bought AXSM
December 31, 2025 · Form 4 insider transaction
Saad Mark E bought 6,231 shares of Axsome Therapeutics, Inc. at $8.02 per share, a transaction worth $50.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,231
Price
$8.02
Total value
$50.0K
InsiderSaad Mark E
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 31, 2025
Filing dateJanuary 2, 2026
Shares owned after16,233
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an exercise of stock options prior to the 10-year expiration date of such options.; Such transaction was pursuant to a pre-approved 10b5-1 plan.